KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients. (Q51317485)

3 April 2018

title

KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients. (English)

1 reference

3 April 2018

author name string

Qing Li

1

1 reference

3 April 2018

Miao Chen

2

1 reference

3 April 2018

Rong Zhang

3

1 reference

3 April 2018

Feng Jiang

4

1 reference

3 April 2018

Jie Wang

5

1 reference

3 April 2018

Jian Zhou

6

1 reference

3 April 2018

Yuqian Bao

7

1 reference

3 April 2018

Cheng Hu

8

1 reference

3 April 2018

Weiping Jia

9

1 reference

3 April 2018

publication date

1 October 2014

1 reference

3 April 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

3 April 2018

volume

41

1 reference

3 April 2018

issue

10

1 reference

3 April 2018

page(s)

748-754

1 reference

3 April 2018

Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Gliclazide modified release: results of a 2-year study in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Focus on Kir6.2: a key component of the ATP-sensitive potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12280

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12280

1 reference

3 April 2018

PubMed ID

25115353

1 reference

3 April 2018